FENC
Fennec Pharmaceuticals Inc. - Common Stock (FENC)
$71
About Fennec Pharmaceuticals Inc. - Common Stock (FENC)
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Details
Daily high
$12.12
Daily low
$10.97
Price at open
$11.12
52 Week High
$13.25
52 Week Low
$5.65
Market cap
382.2M
Dividend yield
-
Volume
391,703
Avg. volume
155,059
P/E ratio
736.49
Fennec Pharmaceuticals Inc. - Common Stock News
Details
Daily high
$12.12
Daily low
$10.97
Price at open
$11.12
52 Week High
$13.25
52 Week Low
$5.65
Market cap
382.2M
Dividend yield
-
Volume
391,703
Avg. volume
155,059
P/E ratio
736.49